Skeletal research in an adult rat model reported increased periosteal bone formation when the secretagogue was studied alongside glucocorticoid exposure [5]
ASL is funded by the National Institutes of Health grant 5T32DK007135-46
These insights have driven the development of synthetic GLP-1R/GCGR co-agonists aimed at achieving long-term metabolic benefits
Whats not included: Coaching, dietitian access, nutrition programming, community support, or labs
In animal studies, GLP1-agonists were associated with reduced fetal weight and/or growth, delayed ossification and skeletal variants, usually associated with a reduction in maternal weight gain and decreased food consumption
"We're not talking about stars who need to lose 10 lbs